BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, December 25, 2025
See today's BioWorld
Home
» Financings for Feb. 10, 2021
To read the full story,
subscribe
or
sign in
.
Financings for Feb. 10, 2021
Feb. 10, 2021
Biopharmas raising money in public or private financings, including: Adicet Bio, Angion Biomedica, Assertio Holdings, Autolus Therapeutics, Bighat Biosciences, Bionomics, Biophytis, Bolt Biotherapeutics, Cassava Sciences, Codiak Biosciences, Day One Biopharmaceuticals, Enlivex Therapeutics, Evaxion Biotech, Immunocore, Iterum Therapeutics, Kalvista Pharmaceuticals, Mereo Biopharma Group, Mydecine Innovations, Notch Therapeutics, Mainpointe, Oncorus, Pharvaris, Replicel, Revive, Silo, SQZ, Stealth, Terns, Tonix, Vallon, Vor, Xortx.
BioWorld
Briefs
Financings